PL346645A1 - IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE - Google Patents

IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE

Info

Publication number
PL346645A1
PL346645A1 PL34664599A PL34664599A PL346645A1 PL 346645 A1 PL346645 A1 PL 346645A1 PL 34664599 A PL34664599 A PL 34664599A PL 34664599 A PL34664599 A PL 34664599A PL 346645 A1 PL346645 A1 PL 346645A1
Authority
PL
Poland
Prior art keywords
polysaccharide
propionamido
immunogenic
acryloylated
protein conjugate
Prior art date
Application number
PL34664599A
Inventor
Francis Michon
Chun-Hsien Huang
Catherine Uitz
Original Assignee
North American Vaccine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine filed Critical North American Vaccine
Publication of PL346645A1 publication Critical patent/PL346645A1/en

Links

PL34664599A 1998-08-19 1999-08-18 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE PL346645A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9712098P 1998-08-19 1998-08-19

Publications (1)

Publication Number Publication Date
PL346645A1 true PL346645A1 (en) 2002-02-25

Family

ID=22261244

Family Applications (1)

Application Number Title Priority Date Filing Date
PL34664599A PL346645A1 (en) 1998-08-19 1999-08-18 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE

Country Status (2)

Country Link
PL (1) PL346645A1 (en)
RU (1) RU2249463C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116943055A (en) * 2023-03-07 2023-10-27 上海市第六人民医院 Application of wearable flexible ultrasound in treatment of viral pneumonia

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2378015C2 (en) * 2008-04-02 2010-01-10 Равшан Иноятович Атауллаханов Conjugate for immunisation and vaccination and method for improving immunogenicity
RU2380709C1 (en) * 2008-05-14 2010-01-27 Общество с ограниченной ответственностью "Биотехнология 08" Method for tray sensitisation for polysaccharide antigen enzyme immunoassay
RU2580620C2 (en) * 2010-08-23 2016-04-10 ВАЙЕТ ЭлЭлСи STABLE COMPOSITIONS OF ANTIGENS Neisseria meningitidis rLP2086
CA2921162A1 (en) 2013-05-01 2014-11-06 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
ATE121947T1 (en) * 1989-12-14 1995-05-15 Ca Nat Research Council IMPROVED MENINGOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE.
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116943055A (en) * 2023-03-07 2023-10-27 上海市第六人民医院 Application of wearable flexible ultrasound in treatment of viral pneumonia

Also Published As

Publication number Publication date
RU2249463C2 (en) 2005-04-10

Similar Documents

Publication Publication Date Title
HUP0103100A3 (en) Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
EP1003549A4 (en) Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
IL96676A0 (en) Improved meningococcal polysaccharide conjugate vaccine
AU3198200A (en) Prrsv vaccines
HUS1300072I1 (en) Vaccine
AU6600300A (en) Pneumococcal vaccines
GB9826069D0 (en) HIV vaccine
IL189736A0 (en) Vaccine adjuvants
AU7123500A (en) Polysialic acid-klh conjugate vaccine
GB9915204D0 (en) Vaccine
AU4450696A (en) Enhanced immunogenic vaccine
GB9611673D0 (en) Meningococcal vaccine
CZ20011896A3 (en) Immunogenic preparation and antibody
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
AU2754599A (en) Mucosal microparticle conjugate vaccine
AP2001002076A0 (en) Hiv vaccine
HUP0002359A3 (en) Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
GB9922700D0 (en) Vaccine
GB9909072D0 (en) Vaccine
AU2002336375A1 (en) Improved conjugate vaccines
HK1037862A (en) Vaccine
HK1032202A (en) Adjuvanted vaccine formulation
GB9904408D0 (en) Vaccine
GB9917144D0 (en) Vaccine

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patents lapsed